Poland· PL-100512944
Gohibic
A complement inhibitors product containing vilobelimab, registered in Poland by InflaRx GmbH.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- vilobelimab
- Manufacturer
- InflaRx GmbH
- Country
- Poland (PL)
- ATC code
- L04AJ
- ATC class
- Complement inhibitors
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vilobelimab in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumGohibic 200 mgInflaRx
- CzechiaGOHIBICInflaRx GmbH, Jena
- FinlandGohibicInflaRx GmbH
- IrelandGohibic 200 mg Concentrate for solution for infusionInflaRx GmbH
- IcelandGohibicInflaRx GmbH
- SwedenGohibic 200 mg Koncentrat till infusionsvätska, lösningInflaRx GmbH
- NetherlandsGohibic 200 mg concentraat voor oplossing voor infusieInflaRx GmbH
- United StatesGOHIBICInflaRx GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Gohibic
- Liechtenstein · Gohibic
- Norway · Gohibic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac801d4b-0116-4ab4-9e76-8c6fca1bb5f8 GET /v1/drugs/ac801d4b-0116-4ab4-9e76-8c6fca1bb5f8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "200 mg",
"packaging": "Rp ¦ EU/1/24/1884/001 ¦ 160389\n4 fiol. 20 ml",
"substance": "vilobelimab 200 mg",
"common_name": "vilobelimab",
"pl_product_id": "100512944",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about vilobelimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.